A Slow–Moving Giant Leaps into Bioresearch

While many of the leaders in the chemical and pharmaceutical industries rushed to invest in biotechnology over the past decade, W. R. Grace seemed to sit idle. But now that the multinationals have completed their first round of investments at top dollar and biotechnology novices have begun feeling the pain of long-term research financing, the sleeping giant seems to have awakened.